Argos Therapeutics Company
Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.
%20.jpg)
%20.jpg)
%20.jpg)
Funding Status:
IPO
Headquarters:
Durham, North Carolina, United States
Founded Date:
1997
Investor Type:
For Profit
Technology:
Neurological Disorders
Employee Number:
101-250
Estimated Revenue:
$50M to $100M
Industry:
PharmTech